Vaccination for communicable endemic diseases: optimal allocation of initial and booster vaccine doses.
Humans
Immunization, Secondary
/ statistics & numerical data
Endemic Diseases
/ prevention & control
Mathematical Concepts
COVID-19
/ prevention & control
Vaccination
/ statistics & numerical data
Computer Simulation
COVID-19 Vaccines
/ administration & dosage
Models, Biological
Influenza, Human
/ prevention & control
SARS-CoV-2
/ immunology
Quality-Adjusted Life Years
Influenza Vaccines
/ administration & dosage
Communicable Diseases
/ epidemiology
COVID-19
Dynamic disease model
Epidemic control
Health policy
Optimization
Vaccine allocation
Journal
Journal of mathematical biology
ISSN: 1432-1416
Titre abrégé: J Math Biol
Pays: Germany
ID NLM: 7502105
Informations de publication
Date de publication:
26 Jun 2024
26 Jun 2024
Historique:
received:
04
10
2023
accepted:
24
05
2024
revised:
08
05
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
26
6
2024
Statut:
epublish
Résumé
For some communicable endemic diseases (e.g., influenza, COVID-19), vaccination is an effective means of preventing the spread of infection and reducing mortality, but must be augmented over time with vaccine booster doses. We consider the problem of optimally allocating a limited supply of vaccines over time between different subgroups of a population and between initial versus booster vaccine doses, allowing for multiple booster doses. We first consider an SIS model with interacting population groups and four different objectives: those of minimizing cumulative infections, deaths, life years lost, or quality-adjusted life years lost due to death. We solve the problem sequentially: for each time period, we approximate the system dynamics using Taylor series expansions, and reduce the problem to a piecewise linear convex optimization problem for which we derive intuitive closed-form solutions. We then extend the analysis to the case of an SEIS model. In both cases vaccines are allocated to groups based on their priority order until the vaccine supply is exhausted. Numerical simulations show that our analytical solutions achieve results that are close to optimal with objective function values significantly better than would be obtained using simple allocation rules such as allocation proportional to population group size. In addition to being accurate and interpretable, the solutions are easy to implement in practice. Interpretable models are particularly important in public health decision making.
Identifiants
pubmed: 38926228
doi: 10.1007/s00285-024-02111-x
pii: 10.1007/s00285-024-02111-x
doi:
Substances chimiques
COVID-19 Vaccines
0
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
21Subventions
Organisme : NIDA NIH HHS
ID : R37-DA15612
Pays : United States
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Babus A, Das S, Lee S (2023) The optimal allocation of Covid-19 vaccines. Econ Lett 224:111008
doi: 10.1016/j.econlet.2023.111008
Becker N, Starczak D (1997) Optimal vaccination strategies for a community of households. Math Biosci 139(2):117–32
doi: 10.1016/S0025-5564(96)00139-3
Buckner J, Chowell G, Springborn M (2021) Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers. Proc Natl Acad Sci USA 118:16
doi: 10.1073/pnas.2025786118
Dagpunar J, Wu C (2023) Sensitivity of endemic behaviour of COVID-19 under a multi-dose vaccination regime, to various biological parameters and control variables. R Soc Open Sci 10(5):221277
doi: 10.1098/rsos.221277
Enayati S, Özaltn O (2019) Optimal influenza vaccine distribution with equity. Eur J Oper Res 283(2):714–725
doi: 10.1016/j.ejor.2019.11.025
Han S et al (2021) Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity. Nat Commun 12(1):4673
doi: 10.1038/s41467-021-24872-5
Ko Y et al (2021) COVID-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the Republic of Korea. Int J Environ Res Public Health 18(12):6429
doi: 10.3390/ijerph18126469
Matrajt L et al (2021) Vaccine optimization for COVID-19: who to vaccinate first? Sci Adv 7(6):eabf1374
doi: 10.1126/sciadv.abf1374
May R, Anderson R (1984) Spatial heterogeneity and the design of immunization programs. Math Biosci 72(1):83–111
doi: 10.1016/0025-5564(84)90063-4
National Academies of Sciences, Engineering, and Medicine Committee on Equitable Allocation of Vaccine for the Novel Coronavirus (2020) Equitable allocation of vaccine for the novel Coronavirus. National Academy of Sciences, Engineering and Medicine, Washington, DC
Olivares A, Staffetti E (2021) Optimal control applied to vaccination and testing policies for COVID-19. Mathematics 9(23):3100
doi: 10.3390/math9233100
Our World in Data (2022) Daily COVID-19 vaccine doses administered. https://ourworldindata.org/grapher/daily-covid-19-vaccination-doses?tab=chart &country=USA
Rao I, Brandeau M (2021a) Optimal allocation of limited vaccine to control an infectious disease: simple analytical conditions. Math Biosci 337:106821
doi: 10.1016/j.mbs.2021.108621
Rao I, Brandeau M (2021b) Optimal allocation of limited vaccine to minimize the effective reproduction number. Math Biosci 339:108654
doi: 10.1016/j.mbs.2021.108654
Rao I, Brandeau M (2022) Sequential allocation of vaccine to control an infectious disease. Math Biosci 351:108879
doi: 10.1016/j.mbs.2022.108879
Rodrigues H, Monteiro M, Torres D (2013) Vaccination models and optimal control strategies to dengue. Math Biosci 247:1–12
doi: 10.1016/j.mbs.2013.10.006
Saad-Roy C et al (2020) Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science 370(6518):811–818
doi: 10.1126/science.abd7343
Saldana F et al (2023) Optimal vaccine allocation for the control of sexually transmitted infections. J Math Biol 86(5):75
doi: 10.1007/s00285-023-01910-y
Sun A et al (2022) SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect Dis 22(1):439
doi: 10.1186/s12879-022-07418-y
Tanner M, Sattenspiel L, Ntaimo L (2008) Finding optimal vaccination strategies under parameter uncertainty using stochastic programming. Math Biosci 215(2):144–51
doi: 10.1016/j.mbs.2008.07.006
Tran T et al (2021) Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts. BMC Med 19(1):162
doi: 10.1186/s12916-021-02038-w
Yarmand H et al (2014) Optimal two-phase vaccine allocation to geographically different regions under uncertainty. Eur J Oper Res 233(1):208–219
doi: 10.1016/j.ejor.2013.08.027
Yuzo Miyaoka T, Lenhart S, Meyer J (2019) Optimal control of vaccination in a vector-borne reaction–diffusion model applied to Zika virus. J Math Biol 79(3):1077–1104
doi: 10.1007/s00285-019-01390-z
Zaric G, Brandeau M (2001) Resource allocation for epidemic control over short time horizons. Math Biosci 171(1):33–58
doi: 10.1016/S0025-5564(01)00050-5
Zhu J, Wang Q, Huang M (2023) Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: the case of COVID-19. Front Public Health 11:129183